Abstract:Intestinal dysfunction is frequently driven by abnormalities of specific genes, microbiota, or microenvironmental factors, which usually differ across individuals, as do intestinal physiology and pathology. Therefore, it's necessary to develop personalized therapeutic strategies, which are currently limited by the lack of a simulated intestine model. The mature human intestinal mucosa is covered by a single layer of columnar epithelial cells that are derived from intestinal stem cells (ISCs). The complexity of the organ dramatically increases the difficulty of faithfully mimicking in vivo microenvironments. However, a simulated intestine model will serve as an indispensable foundation for personalized drug screening. In this article, we review the advantages and disadvantages of conventional 2-dimensional models, intestinal organoid models, and current microfluidic intestine-on-a-chip (IOAC) models. The main technological strategies are summarized, and an advanced microfluidic primary IOAC model is proposed for personalized intestinal medicine. In this model, primary ISCs and the microbiome are isolated from individuals and co-cultured in a multi-channel microfluidic chip to establish a microengineered intestine device. The device can faithfully simulate in vivo fluidic flow, peristalsis-like motions, host-microbe crosstalk, and multi-cell type interactions. Moreover, the ISCs can be genetically edited before seeding, and monitoring sensors and post-analysis abilities can also be incorporated into the device to achieve high-throughput and rapid pharmaceutical studies. We also discuss the potential future applications and challenges of the microfluidic platform. The development of cell biology, biomaterials, and tissue engineering will drive the advancement of the simulated intestine, making a significant contribution to personalized medicine in the future.

Current Gut-on-a-chip Platforms for Clarifying the Interactions Between Diet, Gut Microbiota, and Host Health

[Advances of gut-on-a-chip for exploring host-microbe interactions]

Gut-on-chip: Recreating human intestine in vitro

Emerging microfluidic gut-on-a-chip systems for drug development

Advanced gut-on-chips for assessing carotenoid absorption, metabolism, and transport

Microfluidic Gut-on-a-Chip: Fundamentals and Challenges

Simulator of the Human Intestinal Microbial Ecosystem (SHIME®): Current Developments, Applications and Future Prospects

Gut-on-a-chip for disease models

Recent Advances in Gut‐ and Gut‐Organ‐Axis‐on‐a‐Chip Models

Intestine-on-a-chip: Next level in vitro research model of the human intestine

Primary exploration of host–microorganism interaction and enteritis treatment with an embedded membrane microfluidic chip of the human intestinal–vascular microsystem

The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology

The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip

Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip

Establishment and Evaluation of On-Chip Intestinal Barrier Biosystems Based on Microfluidic Techniques

Lab-on-chip technologies for exploring the gut-immune axis in metabolic disease

Intestine‐on‐a‐chip for Intestinal Disease Study and Pharmacological Research

Establishment of a Gut-on-a-chip Device with Controllable Oxygen Gradients to Study the Contribution of Bifidobacterium Bifidum to Inflammatory Bowel Disease.

Current in Vitro and Animal Models for Understanding Foods: Human Gut-Microbiota Interactions.

Advances in reconstructing intestinal functionalities in vitro: From two/three dimensional-cell culture platforms to human intestine-on-a-chip